Extracorporeal Carbon Dioxide Removal Devices Market Fortune Business Insights report covers a detailed study of the Extracorporeal Carbon Dioxide Removal Devices Market size

(The Express Wire via Comtex)

The global extracorporeal carbon dioxide removal (ECCO2R) devices market is expected to gain impetus from a rise in the aging population reported worldwide. According to an upcoming report by Fortune Business Insights, titled, “Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Size, Share and Global Trend By Product (Extracorporeal CO2 Machines, Disposables), Application (Chronic Pulmonary Obstructive Disease, Acute Respiratory Distress Syndrome, Bridge to Transplant), Access (Venovenous Access, Arteriovenous Access), End Users (Clinics, Ambulatory Surgery Centres, Hospitals) and Geography Forecast till 2025,” increasing prevalence of chronic pulmonary obstructive disease and rising incidence of acute respiratory distress will contribute to the global ECCO2R devices market growth in the forthcoming years. The report provides a detailed analysis of all the segments on the bases of country, region, and world. It further offers elaborate information the growth opportunities, hindrances, driving factors, challenges, and geography.

For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/extracorporeal-carbon-dioxide-removal-ecco2r-devices-market-100353

Clinical Benefits Offered by ECCO2R Devices Expected to Propel Global Market Growth

The World Health Organization (WHO) declared that approximately 251 million people across the world were suffering from chronic pulmonary obtrusive disorder in 2016. WHO predicted that the cases of pulmonary obtrusive disorder are likely to rise by 2026 due to a rise in smoking amongst the populace, which, in turn, is anticipated to increase the global extracorporeal carbon dioxide removal (ECCO2R) devices market sales in the coming years. Furthermore, clinical advantages provided by ECCO2R removal devices, such as efficient gas exchange, vitalizing blood flow, and robust lung support are projected to propel the global ECCO2R devices market revenue during the forecast period.

Request a Sample Copy of the Global Extracorporeal Carbon Dioxide Removal Devices Market:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/extracorporeal-carbon-dioxide-removal-ecco2r-devices-market-100353

Ongoing Developments in Healthcare Infrastructure to Favor Growth in Asia Pacific

Geographically, the global extracorporeal carbon dioxide removal (ECCO2R) devices market is grouped into the Middle East and Africa, Latin America, Asia Pacific, Europe, and North America. Amongst these, North America is anticipated to lead the global market owing to the increasing adoption of sedentary lifestyle. Moreover, the ever-increasing industrialization is giving rise to air pollution, which is further raising the incidence of acute asthma. The Middle East and Africa and Asia Pacific hold immense growth potential. It is likely to occur because of the ongoing developments in healthcare infrastructure, rising per capita expenditure, and increasing prevalence of respiratory disorders.

Key Segmentation by Extracorporeal Carbon Dioxide Removal Devices Market:

By Product

  • Extracorporeal CO2 Machines
  • Disposables
  • Others

By Application

  • Chronic Pulmonary Obstructive Disease
  • Acute Respiratory Distress Syndrome
  • Bridge to Transplant
  • Others

By Access

  • Venovenous Access
  • Arteriovenous Access

By End User

  • Clinics
  • Ambulatory Surgery Centres
  • Hospitals

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)

ALung Technologies Receives CE Approval for its Hemolung Respiratory Assist System

ALung Technologies, Inc., a leading manufacturer of medical equipment, based in the U.S., declared in February 2013 that it has received approval from CE for its Hemolung Respiratory Assist System (RAS). The receipt from CE Mark will help the company in selling Hemolung RAS in the European Union. The system removes carbon dioxide and provides oxygen directly to the patient’s blood with the help of respiratory dialysis. It further allows the patient’s lungs to rest and heal. In 2011, ALung had successfully completed a clinical trial of the device. It has also received a Health Canada License. According to the company, Hemolung RAS is one of the first devices to offer low-flow, efficient, and simple carbon dioxide removal for those affected by acute respiratory failure.

ALung Receives IDE Approval for Hemolung RAS to Perform Vent-Avoid Trial

In September 2017, ALung Technologies, Inc. announced that its Hemolung Respiratory Assist System (RAS) has received approval of Investigational Device Exemption (IDE). It was approved for conducting a vital clinical trial of the system for the treatment of adult patients who are suffering from acute exacerbation of chronic obstructive pulmonary disease (COPD). It makes the company’s vent-avoid trial the first key trial of ECCO2R for patients affected by COPD exacerbations.

Fortune Business Insights covers some of the leading players operating in the global extracorporeal carbon dioxide removal (ECCO2R) devices market. They are as follows:

  • ALung Technologies, Inc.
  • Getinge AB.
  • Medtronic
  • ESTOR S.P.A
  • XENIOS AG
  • MEDICA S.p.A.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Extracorporeal Carbon Dioxide Removal Devices Market Fortune Business Insights report covers a detailed study of the Extracorporeal Carbon Dioxide Removal Devices Market size

comtex tracking